Skip to main content
. 2018 Mar 6;88(6):920–927. doi: 10.1111/cen.13569

Figure 2.

Figure 2

Symptoms of early ovarian hyperstimulation syndrome (OHSS) by trigger of oocyte maturation administered. The frequency of symptoms of OHSS by trigger of oocyte maturation is presented for patients receiving either human chorionic gonadotrophin (hCG) (n = 40), GnRH agonist (GnRHa; n = 99), or kisspeptin (n = 122). The frequency of symptoms consistent with OHSS including abdominal pain (A), abdominal bloating (B), diarrhoea (C), nausea (D), vomiting (E) and self‐reported reduction in urine output (F) are presented. The odds ratio of experiencing each symptom by trigger of oocyte maturation is presented in Table 1